Dynamic growth, drug innovations and a wealth of experience that have matured over generations are the hallmarks of Berlin-Chemie. The company is part of Italy’s global MENARINI Group and is mainly responsible for business development in Germany, Central and Eastern Europe and is one of the three research centres of the MENARINI Group.
From 1999 to 2017 Berlin-Chemie increased gross sales more than fivefold (€1.74 Billion in 2017) and increased the number of employees in Germany and abroad by about 3.800 to 5.425. Two-thirds of the company's medicines sold domestically are innovative drugs, especially cardiovascular and antidiabetics. Berlin-Chemie supplies medicines to more than 35 countries and maintains its own branches in more than 30 countries.